The Centenarian's Gut Doesn't Look Young, It Looks Different. How to Optimize it

#1

A three-author team from Portugal, Switzerland, and Greece has published a broad narrative synthesis of what is currently known about how the gut microbiome changes with age and whether those changes cause, follow, or merely accompany the decline of the ageing body. The review assembles evidence that ageing guts lose microbial diversity, lose the bacteria that ferment fibre into butyrate, become leakier, and generate more inflammatory signal, and it links this to Alzheimer’s disease, cardiovascular disease, type 2 diabetes, sarcopenia, osteoporosis, and frailty. It then surveys the interventions aimed at reversing this, from Mediterranean diet and exercise through prebiotics, probiotics, and faecal transplant.

The big idea in this review is one the longevity field has been circling for a decade: the community of roughly a hundred trillion microbes in the human colon is not a passive passenger during ageing, but an active participant that may help set the pace of decline.

The observed pattern is now well replicated. From roughly the seventh decade onward, the gut microbiome loses diversity and loses specific fibre-fermenting organisms, particularly Faecalibacterium prausnitzii, Roseburia, and Eubacterium species. These bacteria are the main producers of butyrate, a short-chain fatty acid that feeds colon lining cells directly, tightens the junctions between them, and acts as a brake on inflammatory gene expression. As they thin out, opportunistic organisms such as Escherichia, Klebsiella, and Proteus expand. The gut wall becomes more permeable. Bacterial lipopolysaccharide leaks into the bloodstream. The immune system responds with a low-grade, never-resolving inflammatory hum that gerontologists call inflammaging.

The review’s more interesting move is to argue that this is not inevitable. Studies of Italian centenarians and semi-supercentenarians, and a large American longitudinal cohort, suggest that the very long-lived do not simply preserve a youthful microbiome. They develop a distinctive one. Their gut communities drift away from the population average with age, remaining rich in Akkermansia, Christensenellaceae, and butyrate producers, and they keep the metabolic jobs running even as the taxonomic cast changes. The people who lose that drift, whose guts stay stuck in a common Bacteroides-dominated configuration, do worse.

That reframing has a practical implication the authors draw out. If what matters is metabolic function rather than a particular species list, then the goal of intervention is not to reinstall a specific bacterium but to restore what the community does. The most convincing human evidence for that comes from the NU-AGE trial, in which 612 adults aged 65 to 79 across five European countries followed a Mediterranean diet for a year and showed measurable shifts in microbiome composition alongside improvements in inflammatory markers and frailty measures.

The honest bottom line, which the review states clearly, is that causality in humans remains unproven. Inflammation reshapes the microbiome just as readily as the microbiome drives inflammation. Almost all of the mechanistic proof comes from germ-free mice, whose immune systems and microbiomes differ substantially from ours. The gut microbiome is a serious candidate mechanism of ageing. It is not yet a clear lever.

Actionable Insights

Two things in this literature are worth acting on, and one is worth tracking.

Eat more fibre and more plants. In the NU-AGE trial, a year of Mediterranean eating in older adults produced a diet-to-microbiome relationship of r = 0.39, which converts to a standardised effect size of about d = 0.85. That is a large effect by conventional benchmarks, and it means the diet reliably changed the gut community. The catch is that this is the effect on the bacteria, not on your health. The downstream effects on frailty and inflammation were smaller and were only partly attributable to the microbiome. Practical target: 25 to 35 grams of fibre daily from legumes, whole grains, vegetables, fruit, and resistant starch.

Take the TMAO story with less alarm than it is usually sold with. In the largest study, high blood TMAO raised three-year cardiovascular event risk with a hazard ratio of 2.54, but that fell to 1.43 once kidney function and inflammation were accounted for. Converted to a standardised effect, that is roughly d = 0.20, which is small.

Ignore faecal transplant for longevity. The trials are tiny, uncontrolled, and carry real infection risk in frail people.

Context and Source

  • Open Access Paper: Gut Microbiota and Ageing: Mechanisms, Age-Related Diseases, and Therapeutic Perspectives
  • Institutions: Institute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, Portugal (lead); Institute of Public Health, Università della Svizzera Italiana, Switzerland, and Taras Shevchenko National University of Kyiv, Ukraine; Department of Psychology, Democritus University of Thrace, Greece
  • Journal: Healthcare, MDPI, Basel, Switzerland.
  • Article type: Narrative review.
  • Journal impact evaluation: The impact score of this journal is 3.4 (2025 Journal Impact Factor; CiteScore 5.5), evaluated against a typical high-end range of 0 to 60+ for top general science, therefore this is a Low impact journal.

Related Reading: